In observance of Election Day, Goodwin’s US offices are closed on Tuesday, November 3. We encourage everyone in our community to do their civic duty and vote. The BMW blog will be back on Wednesday, November 4.
The post Election Day in the US appeared first on Big Molecule Watch.
Related Content
- Big Molecule WatchJuly 25, 2024
FDA Issues Draft Guidance on Demonstrating Biosimilar Interchangeability
- Big Molecule WatchJuly 25, 2024
FDA Approves Samsung’s Eculizumab Biosimilar
- Big Molecule WatchJuly 23, 2024
FTC Issues Interim Report on Ongoing Study of Pharmacy Benefit Managers
- Big Molecule WatchJuly 12, 2024
Outlook Therapeutics Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma)
- Big Molecule WatchJuly 9, 2024
Fresenius Announces Launch of Subcutaneous Formulation of TYENNE (tocilizumab-aazg) in the United States
- Big Molecule WatchJuly 9, 2024
FDA Approves Ustekinumab, Aflibercept, and Filgrastim Biosimilars
- Big Molecule WatchJune 28, 2024
Biogen’s TOFIDENCE (tocilizumab) Approved in the EU
- Big Molecule WatchJune 26, 2024
Eculizumab BPCIA Litigation Update: Court Denies Alexion’s Motion for an Injunction Pending Appeal
- Awards and RankingsSeptember 25, 2023
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Twelfth Consecutive Year
- Awards and RankingsOctober 4, 2022
LMG Recognizes Goodwin Lawyers and Practices for Excellence in Life Sciences
- Press ReleaseNovember 17, 2021
Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.
- Awards and RankingsOctober 26, 2021
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Tenth Consecutive Year
- Press ReleaseJune 28, 2021
Goodwin Adds Life Sciences and Healthcare Litigation Partner William Jackson
- EventsDecember 5, 2020
China's Patent Linkage System: Can Strategies that Work in the U.S. System Be Applied to China?
- Awards and RankingsOctober 5, 2020
Goodwin Named An LMG Life Sciences Life Cycle Firm For The Ninth Consecutive Year
- Speaking EngagementsSeptember 23, 2020
ACI's 11th Summit on Biosimilars & Innovator Biologics